Competition Archive » August, 2021

Competition - August, 2021

217 articles

• CP Touts $31B Bid To KCS Shareholders After Rival Hits Snag
• Fenwick Expands To DC With Ex-Dechert, Freshfields Attys
• 3rd Circ. Puts Surgeon's Antitrust Suit Back On Life Support
• 5th Circ. Affirms Ericsson's FRAND Win Over HTC
• TV Streamer Locast Loses Key Ruling In Battle With Networks
• Google Play Store Cases Eyeing Fall 2022 Trial
• Class Attys Get $152M As Sutter Settles Antitrust Case In Calif.
• DOJ Using 'Hammer' For 'Scalpel' Google Discovery: Judge
• UK Antitrust Watchdog Mulls Changes After Settlement Appeal
• Rural ISP Says Rival Spreads Falsehoods In Spectrum Spat
• Robinhood Seeks To Nix MDL Over 'Meme Stock' Restrictions
• Law360 MVP Awards Go To 182 Attys From 77 Firms
• What The Judiciary's Font Recommendations Can Teach Us
• How Firms Can Help Law Schools Leap Into The Future
• Vaccines, Tuition, Race: The Litigation On Law Schools' Radar
• 4 Ideas For Updating Law Schools Post-Pandemic
• Epic 'Fighting On' After Apple's App Store Developer Deal
• Forex-Rigging Case Tainted By Judge Error, 2nd Circ. Told
• Brake Makers' $2.24M Deal Brings Price-Fix Claims To A Halt
• FTC Says Retired Debt Counts Towards Merger Threshold
• NM Franchisee Hits InterContinental With Antitrust Suit
• Dechert Adds Ex-Prosecutor And Ex-Paul Hastings Atty In SF
• 101 Indicted In Transnational Cellphone Trafficking Scheme
• 11th Circ. Judge OK With Jury Instruction In Boeing Case
• Biz Groups End Insurance Price Fight After Compliance Delay
• King & Spalding Nabs Hogan Lovells Antitrust Partner
• Apple To Pay $100M, Alter App Store To End Antitrust Suit
• 2nd Circ. Won't Rehear FTC's 1-800 Contacts Loss
• Zydus To Appeal Takeda's Antitrust Win In Drug Patent Row
• Apple Opposes Epic's Bid To Access Class Action Docs
• TravelPass, Choice Hotels End Legal Fight Over Search Terms
• ProMedica Tells 6th Circ. It Needs Rehearing Answer ASAP
• NJ Hospitals Taking Fight With FTC Over Merger To 3rd Circ.
• $11B Hospital System Not A Local Gov't, Justices Told
• Altria, Juul Seek Upper Hand Against FTC After In-House Trial
• Judge Rejects Most Of Google's Bid To Shield Play Store Info
• Hospital Wants Redo In 6th Circ. ProMedica Contract Appeal
• Another Trucking Co. Settles Out Of No-Poach Suit
• Takeda Can't Duck Generic-Drug Delay Suit At 2nd Circ.
• Advocates Still Not Satisfied With Verizon-TracFone Deal
• Pharmacy Operator Hits Ex-Employee With Trade Secrets Suit
• Germany's MAN Accepts Rival's Costs In Truck Cartel Suit
• FTC, Illumina Clash On Merger's Potential To Win Cancer War
• QVC, Suzanne Somers Can't Stop Dispute From Going To Trial
• Ex-FTC Policy Head Tapped As TechFreedom Senior Counsel
• Glenmark Still Fighting To End DOJ Interviews Of India Execs
• Apple Says It Has No Obligation To Host Rival COVID Apps
• App Makers Ask 9th Circ. To Revive Facebook Antitrust Suit
• DOJ Should Withdraw Improper Intervention In SEP Cases
• US Concrete, Vulcan Deal Closing Without In-Depth Review
• How The 'Rocket Docket' Continues To Roar Through COVID
• UK Antitrust Watchdog Probes S&P's $44B Bid For IHS Markit
• 9th Circ. Asked To Save Golden Globes Monopoly Case
• Biden's Antitrust Policies Won't Depart Entirely From Trump's
• Exec Says He Needs More Than 'Panicky Messages' From DOJ
• Zetia Drug Buyers Win Class Cert. Against Merck, Glenmark
• Health Care M&A Faces Antitrust Enforcement Crackdown
• Top Court NCAA Ruling Can't Save Recruit's Adidas RICO Suit
• Google Wants Play Store Info Shielded Despite Epic Unsealing
• Paul Hastings Nabs Former Top DOJ Antitrust Official
• DC Circ. Expedites Rail Cos. Appeal In Price-Fixing MDL
• COVID Travel Test Firms Warned On 'Unacceptable' Prices
• 9th Circ. Affirms Traveling Nurse Agency's No-Poach Loss
• Juul-Altria Force Some Buyers Into Arb But Can't Duck Suit
• UK Says Nvidia's $40B Arm Deal Raises 'Serious' Concerns
• FTC Hopes Updated Facebook Complaint Plugs Holes In Case
• EU Targets Illumina's Completion Of Grail Deal Amid Probe
• App Store Competition Bill Contains A Loophole
• Steelmaker's Tariff Abuse Suit To Stay In Pa. Federal Court
• Maynard Cooper Grows Iowa Practice With 2 Shareholders
• Ireland Insurers Sign Legal Pledge After Competition Probe
• Apple Created 'Roadblocks' To DOJ's Google Suit, Court Told
• Lexington Insurance Wants Out Of BCBS Antitrust Coverage
• For FCC's Carr, Section 230 Is The New Net Neutrality
• Google Can't Keep App Store Antitrust Allegations Private
• SmileDirect Settles Case Over Alabama Dental Board Rules
• What China's Patent Linkage System Means For US Drug Cos.
• Injunction Granted In TM Dispute Over Cigarette Rolling Paper
• Why A Missed Email Could Cost You Your Case
• KCS Delays Stockholder Vote On $34B Canadian National Bid
• Zuckerman Spaeder Hires Ex-Freshfields Litigator In DC
• FTC Takes Another Shot At Facebook In 3-2 Vote
• 1-800 Contacts Sues Warby Parker Over Search Engine Ads
• Antitrust Class Actions Gather Speed With Mastercard Ruling
• Illumina Completes $7.1B Grail Deal Amid Antitrust Scrutiny
• Locast Exec Wants His Day In Court To 'Exonerate' Himself
• Comcast Calls Viamedia's Privilege Claim 'Gamesmanship'
• Axon Gets More Support For High Court FTC Challenge
• Apple Says DOJ Is Asking It For Too Much Info In Google Case
• Contractor Settlements Highlight Small Biz Compliance Risks
• DOJ Rips Poultry Execs' Early Bid For Docs In Price-Fix Case
• FTC Merger Warning Letters Seen As Largely Superficial
• Excavation Co. Says Employee Stole Bid Secrets For Rival
• Customers Get OK For £14B Mastercard Antitrust Class Action
• Judge Lets Most Of Xyrem Antitrust Suit Against Jazz Survive
• End-Payors Again Denied Cert. In Niaspan Pay-For-Delay MDL
• Saul Ewing Says Mushroom Group's Malpractice Suit Too Late
• DOJ Defends Glenmark, Teva Executive Interviews Abroad
• Realtors Association Escapes Suit Over Listing Policy
• Vape Co. Counters Brand Owner, Says It Broke $1.2M Contract
• These Law Firms Have The Most Diverse Equity Partnerships
• McDonald's Looks To Join Broiler Chicken Price-Fix Litigation
• Biotech Says Celgene-BMS Deal Threatens Drug Development
• Supreme Court Asked To Consider 'Initial Interest' TM Doctrine
• Google Says It's Not A Common Carrier, Seeks Ohio Suit Toss
• Judge Lets Dana-Farber Advance Cancer Drug IP Suit
• Calif. Regulator Targets T-Mobile's 3G Sunset Plans
• Law360's Diversity Snapshot: What You Need To Know
• Fieldfisher Nabs BNYM Lawyer To Boost AML
• Gov't Urged To Get Tough With Ticket Resellers
• Sens. Raise Flag On Amazon's Biometric Data Collection
• Health First Antitrust Suit Left Largely Intact
• DOJ Can't Wash Hands Of Rule From Old Deal, NAR Says
• Tyson Pays $1.5M CFTC Fine Tied To Soybean Position Limits
• DOJ Denies 'Rewriting' Price-Fix Indictment of Glenmark, Teva
• DOJ Gets More Time To Review Optum's $13.8B Change Buy
• Drug Benefit Managers Call Feds' Price Disclosure Rule Faulty
• Clayton Act Takeaways From Endeavor Execs' Live Nation Exit
• VW Investors Ask 2nd Circ. To Revive Car Conspiracy Suit
• 5 Reasons Lawyers Often Fail To Secure Litigation Funding
• TVA Can't Escape Contract Suit From Environmental Groups
• Skadden, Sidley Lead $4B Willis Towers Reinsurance Biz Sale
• Lannett Investors Nab Cert. In Suit Over Price-Fix Probes
• DOJ, FTC Push Fed's Proposal For Virtual Wallets
• Despite Giuliani's Assertion, Lawyers Cannot 'Throw A Fake'
• The Complexity Of COVID-19 Price-Gouging Compliance
• What HSR Filers Should Know About New FTC Warnings
• 9th Circ. Nixes Kalispel Tribe's Bid To Redo Casino Ruling
• Food Distributors Brush Off FTC Merger Warning
• Google Says Epic 'Sidestepping' Safeguards In Redaction Row
• Verizon, Lifeline Advocates Reach Deal On TracFone Tie-Up
• It's Time To Upgrade Our Attorney Licensure Rules
• Biden Wants Congress To Set Sights On Cutting Drug Prices
• Facebook May Have To Unwind $400M Giphy Deal In UK Probe
• Google's Redactions Bid Not About Trade Secrets, Epic Says
• Nuveen Can't Dodge Suit Over Alleged Preston Hollow Boycott
• Senators Float Bill To Boost App Store Competition
• Chamber Sues To Block Health Plan Price Transparency Rule
• DOJ Says Realtor Group Can't Shield Rules With Old Deal
• Gray Fights $500K FCC Fine Over Alaska TV Stations
• Considering Short- And Long-Term Effects Of COVID IP Waiver
• Hospitals Tell DOJ $13.8B Optum-Change Deal Can't Be Fixed
• Peanut Processors To Shell Out $34M In Fees In Price-Fix Suit
• Data-Based Predictions On Case Timelines After Pandemic
• State Regulators Stand Behind FERC Tariff Order At DC Circ.
• 6th Circ. Lets ProMedica Drop Rival's Insurance Contracts
• Oft-Cited Case Involving Anti-Malware Cos. Tossed For Good
• 2nd Circ. Nixes Vitamin C Price-Fixing Case, Again
• Apple Can't Combine COVID-19 App Case With App Store Suit
• State AGs' Google Ad Suit Must Join Private Ones In NY
• The Law On Online Content Moderation And Where It's Headed
• Embracing ESG
• Pa. Judge Rejects QVC Privilege Bid In Suzanne Somers Suit
• UK Watchdog Clears ATM Giants' Merger With No Conditions
• Zimmer Sues NJ Biotech Over Dental Implant Products
• Shire Pays $1.9M, Boosting ADHD Med Antitrust Deal To $3M
• Canadian Pacific Says New $31B KCS Bid Bests Railway Rival
• Groupon Told To Improve Customer Service Or Face Court
• Glenmark, Teva Say DOJ 'Rewriting' Price-Fixing Indictment
• DOJ Blasts Indicted Chicken Exec Over 'Fishing Expedition'
• Clarivate's $5.3B ProQuest Buy Delayed Under FTC Scrutiny
• FTC Wants More Info On AbbVie's $550M Device Deal
• DOJ Concerned About T-Mobile's Planned Network Shutdown
• Jeld-Wen Gets Adviser Info Shielded In Door Factory Sale
• FTC Asks 2nd Circ. To Rethink 'Free Pass' For 1-800 Contacts
• Retention Is Key To Meaningful Diversity At Law Firms
• Canadian Watchdog Probes Wireless Cos.' $21B Merger Plan
• Uber Defeats Cab Cos.' $122M Antitrust Suit At 1st Circ.
• Free Market Group Backs Axon's High Court Challenge Of FTC
• CBS Works Out Deal To End Claims In Ad Price-Fixing MDL
• DC Circ. Faults FERC's 'Breezy' Power Price Spike Review
• Home Sellers Blast Keller Williams' Subpoena Bid In NAR Row
• Valeant To Pay $23M To End 'Secret' Pharmacy RICO Claims
• Sainsbury's Settles Swipe Fee Case Against Mastercard
• Perkins Coie Adds Ex-Wilson Sonsini Antitrust Atty
• Pilgrim's To Pay $76M To Settle Chicken Price-Fixing Claims
• PTAB Lets Samsung Drop Reviews, Not Show Ericsson Pact
• Investors Say They Have 'Smoking Gun' In Auction-Fixing Suit
• Texas Drops Some Google Damages Claims To Avoid Transfer
• Court Mulls Sliding Scale For Fees In Chicken Antitrust Suit
• Germany Fines Musical Instrument Makers €21M Over Pricing
• Monetary Remedies After High Court FTC Ruling
• Teva Piles Onto Strong-Arm Tactic Accusations Against DOJ
• Pfizer Accused Of Illegally Inflating Epilepsy Drug Price In UK
• Visa, Mastercard ATM Fee Antitrust Classes Get Certs
• Banks Fight Class Cert. Bid In Stock Loan Antitrust Suit
• FTC Gets New Jersey Hospital Merger Paused
• Deal Maker Takeaways From Latest CFIUS Annual Report
• How Citizen Petitions Influence FDA Drug Approvals
• Prospects Look Strong For UK Class Actions
• Winning Firms In NCAA High Court Fight Add $3.5M To Haul
• Zetia Judge Must Rethink 'Faulty' Class Cert., 4th Circ. Says
• DOJ's 1st Wage-Fixing Trial Set For April 2022
• 5th Circ. Denies Antitrust Immunity For Texas River Authority
• Avoiding Unauthorized Practice Of Law In Remote Work
• Drug Price Checker Replies To Pharma Group's Counterclaims
• Reed Smith Snags Chamber Lawyer For State AG Practice
• Bond Investors Seek 2nd Circ. Redo In Market-Rigging Suit
• FTC Says Illumina Case Too Simple For Extra Experts
• 9th Circ. Will Rethink Tuna Buyers' Class Decertification
• FTC Warning Cos. About Unfinished Merger Reviews
• Glenmark Accuses DOJ Of 'Strong-Arm Tactics'
• What To Know About GOP Senators' Latest Data Privacy Push
• CMA Won't Review Baker Hughes, Akastor Offshore Drilling JV
• Mich. Health Providers Face Suit Over 'No Poach' Agreement
• Takeda Kept Generic Drug Off Shelves For 6 Years, Suit Says
• EU Offers National Courts Guidance On State Aid
• Ex-Jimmy John's Worker's Cert. Bid In No-Poach Suit Tossed
• The Non-Tech Antitrust Conduct Cases Defining 2021
• Grubhub Looks To Arbitrate NYC Bakery's Fee Cap Suit
• DOJ Says It Told Glenmark About Compulsory Exec Interviews
• Impax Inks $33M Deal With Investors In Price-Fixing Suit
• DOJ Eyes Dec. Trial In 1st Wage-Fixing Prosecution
• SEC Fines Ernst & Young $10M Over Bid To Nab Big Client
• 3 Firms Rep IHS Markit's $1.2B Divestment To News Corp.
• Monthly Merger Review Snapshot
• EU Taking Deeper Look At Facebook's Kustomer Deal